Researchers discovered a satellite virus latching onto the neck of another virus called MindFlayer. Studying the viral arms race between similar viruses could lead to new ways to fight infections.
Academic rigour, journalistic flair
Articles on Antivirals
Displaying 1 - 20 of 26 articles
The human body has been making antivirals for eons, long before scientists did. A protein in your cells called viperin produces molecules that work similarly to the COVID-19 antiviral remdesivir.
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
It can be difficult to an appointment to see your GP. So when should you make the effort to see a GP for a prescription for influenza antivirals? And how effective are they?
People in disadvantaged communities are less likely to access COVID antivirals. That needs to change.
We know from other viruses that viral fragments can remain in different tissues for months or even years. This could be the case for long COVID.
People with Down syndrome have an extra chromosome 21. Understanding the effects of those triplicated genes could help improve the health of those with Down syndrome and other medical conditions.
While RSV can become severe for any child, it poses a particularly serious threat for the youngest babies and for high-risk children.
Declaring monkeypox a national health emergency will allow the U.S. government to direct resources and funds where needed to help slow the spread of the virus.
After taking Paxlovid for COVID and appearing to recover, some people – including US President Joe Biden – continue to test positive. What’s going on?
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began taking an antiviral drug the morning he tested positive.
If you do get COVID and you’re eligible for antiviral treatment, you’ll want to get them quickly. That’s why being prepared is a good idea.
After testing positive for COVID, your medicine prescription will depend on the severity of your symptoms and any other health conditions you have.
Here’s who is eligible, the benefits and side effects to consider.
An infectious disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
Earlier detection and treatment of COVID-19 by health care providers in pharmacies could help prevent surges in infection rates and severe illness.
Most people with COVID will recover at home without any treatment. But some people who are at risk of severe disease could benefit from new medicines to reduce the chance of the disease progressing.
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
Researchers around the world are using new and existing technology to develop potential treatments for those with COVID-19. Here’s what’s in development in Australia.
Top contributors
-
Assistant Professor of Infectious Diseases, University of Virginia
-
Post doctoral researcher and medical epidemiologist, The Peter Doherty Institute for Infection and Immunity
-
Director, Evidence and Methods, National COVID-19 Clinical Evidence Taskforce; Associate Professor (Research), Cochrane Australia, School of Population Health and Preventive Medicine, Monash University, Monash University
-
Monash University
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Epidemiology, University of San Francisco
-
Professional Research Fellow, Victoria University
-
Research Officer - Immunology and Translational Research, Victoria University
-
Pharmacist and PhD Candidate, University of Sydney
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Director Intensive Care Unit Alfred Health and Adjunct Associate Professor Epidemiology and Preventative Medicine Monash University, The National Trauma Research Institute
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Professor and Laboratory Head, The University of Melbourne
-
Professor of general practice, Bond University
